Mehra Anand 4
4 · Aclaris Therapeutics, Inc. · Filed Jun 4, 2024
Insider Transaction Report
Form 4
Mehra Anand
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-01+4,660→ 43,364 total - Exercise/Conversion
Restricted Stock Units
2024-06-01−4,660→ 0 total→ Common Stock (4,660 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]The shares underlying these restricted stock units vested on June 1, 2024.